Wada N, Murakami T, Fauzi M, et al. Elevated Serum Growth Differentiation Factor 15 Levels as a Potential Biomarker of the Efficacy of Imeglimin in Individuals With Type 2 Diabetes Mellitus: An Exploratory Study. J Clin Med Res. 2024;16(10):503-508. doi:10.14740/jocmr6031